Genetics, Vol. 166, 729-739, February 2004, Copyright © 2004

Identification of Edc3p as an Enhancer of mRNA Decapping in Saccharomyces cerevisiae

Meenakshi Kshirsagara and Roy Parkera
a Department of Molecular and Cellular Biology and Howard Hughes Medical Institute, University of Arizona, Tucson, Arizona 85721-0106

Corresponding author: Roy Parker, Life Sciences South Bldg., 1007 E. Lowell St., University of Arizona, Tucson, AZ 85721-0106., rrparker{at}u.arizona.edu (E-mail)

Communicating editor: P. ANDERSON


*  ABSTRACT
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

The major pathway of mRNA decay in yeast initiates with deadenylation, followed by mRNA decapping and 5'–3' exonuclease digestion. An in silico approach was used to identify new proteins involved in the mRNA decay pathway. One such protein, Edc3p, was identified as a conserved protein of unknown function having extensive two-hybrid interactions with several proteins involved in mRNA decapping and 5'–3' degradation including Dcp1p, Dcp2p, Dhh1p, Lsm1p, and the 5'–3' exonuclease, Xrn1p. We show that Edc3p can stimulate mRNA decapping of both unstable and stable mRNAs in yeast when the decapping enzyme is compromised by temperature-sensitive alleles of either the DCP1 or the DCP2 genes. In these cases, deletion of EDC3 caused a synergistic mRNA-decapping defect at the permissive temperatures. The edc3{Delta} had no effect when combined with the lsm1{Delta}, dhh1{Delta}, or pat1{Delta} mutations, which appear to affect an early step in the decapping pathway. This suggests that Edc3p specifically affects the function of the decapping enzyme per se. Consistent with a functional role in decapping, GFP-tagged Edc3p localizes to cytoplasmic foci involved in mRNA decapping referred to as P-bodies. These results identify Edc3p as a new protein involved in the decapping reaction.


IN eukaryotic cells, mRNA turnover and its regulation are essential determinants of gene expression. In Saccharomyces cerevisiae, a major pathway of mRNA turnover for both stable and unstable transcripts initiates with deadenylation of the 3'-polyadenosine [poly(A)] tail (MUHLRAD and PARKER 1992 Down; DECKER and PARKER 1993 Down). The deadenylation of transcripts is followed by the removal of the 5' 7meGTP cap and, subsequently, exonucleolytic digestion of the transcript occurs in the 5'–3' direction (DECKER and PARKER 1993 Down; HSU and STEVENS 1993 Down; MUHLRAD et al. 1994 Down, MUHLRAD et al. 1995 Down; BEELMAN et al. 1996 Down). Several important proteins involved in different steps of the mRNA decay pathway have been characterized (TUCKER and PARKER 2000 Down). The deadenylation step in the decay pathway requires Ccr4p and Pop2p, which are components of the major cytoplasmic deadenylase in S. cerevisiae (DAUGERON et al. 2001 Down; TUCKER et al. 2001 Down, TUCKER et al. 2002 Down; CHEN et al. 2002 Down). After removal of the tail, the Dcp1p/Dcp2p complex decaps mRNAs at their 5' end (BEELMAN et al. 1996 Down; DUNCKLEY and PARKER 1999 Down; STEIGER and PARKER 2002 Down; STEIGER et al. 2003 Down), which then allows Xrn1p, the major yeast 5'–3' exonuclease, to rapidly degrade the body of the transcript.

Decapping is an important step in the mRNA decay pathway as it allows the final degradation of the mRNA and is regulated by a number of proteins (MUHLRAD et al. 1994 Down, MUHLRAD et al. 1995 Down; TUCKER and PARKER 2000 Down). Apart from the decapping enzyme, which consists of Dcp1p and Dcp2p, several proteins including Pat1p, Dhh1p, the Sm-like (Lsm) complex (Lsm1p–Lsm7p), and Edc1p and Edc2p are enhancers of the decapping rate (HATFIELD et al. 1996 Down; BONNEROT et al. 2000 Down; BOUVERET et al. 2000 Down; THARUN et al. 2000 Down; COLLER et al. 2001 Down; DUNCKLEY et al. 2001 Down; HE and PARKER 2001 Down; THARUN and PARKER 2001 Down; FISCHER and WEIS 2002 Down). Lsm1p is part of the seven-member Lsm complex that binds to mRNA and is required for efficient decapping (THARUN et al. 2000 Down). Pat1p is known to interact with the Lsm complex and is an enhancer of decapping (HE and PARKER 2001 Down). Dhh1p is a member of the DEAD-box helicase proteins and is also required for efficient decapping (COLLER et al. 2001 Down). Edc1p and Edc2p are related proteins that are known to affect the decapping enzymes directly and are both enhancers of decapping (DUNCKLEY et al. 2001 Down; SCHWARTZ et al. 2003 Down; STEIGER et al. 2003 Down). Whether additional proteins are involved in decapping is not yet known.

One way to find new factors affecting mRNA decay is to utilize databases of protein-protein interactions on the basis of high-throughput two-hybrid screens, systematic mass spectrometry, and multidimensional protein identification technology screens to find proteins that show numerous interactions with known decapping factors. To do this, we examined the S. cerevisiae genomic-scale data and observed that the yeast open reading frame Yel015W showed numerous interactions with the Dcp1p/Dcp2p complex, Dhh1p, Xrn1p, Pat1p, and members of the Lsm complex (FROMONT-RACINE et al. 1997 Down, FROMONT-RACINE et al. 2000 Down; SCHWIKOWSKI et al. 2000 Down; UETZ et al. 2000 Down; HISHIGAKI et al. 2001 Down; ITO et al. 2001 Down; GAVIN et al. 2002 Down; GIAEVER et al. 2002 Down; HO et al. 2002 Down). This in silico analysis predicts Edc3p to be involved in mRNA turnover. In this study, we present experimental evidence that although Edc3p is not required for decapping, Edc3p can stimulate the rate of decapping in vivo and is found in sites of decapping in the cytoplasm.


*  MATERIALS AND METHODS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Sequence analysis:
The Edc3p homolog in S. pombe was used as a query to identify homologs in other organisms using the BLAST algorithm (ALTSCHUL et al. 1990 Down). Protein sequences of Edc3p and its homologs were aligned using the CLUSTAL W program (THOMPSON et al. 1994 Down). The domains were identified using the BLOCKS program (HENIKOFF et al. 1995 Down) and the position of the domains in the protein was used to draw a cartoon of the Edc3p and its homologs in Fig 1. The accession numbers for the proteins are listed in the legend to Fig 1.



View larger version (46K):
In this window
In a new window
Download PPT slide
 
Figure 1. The Edc3p family of proteins has five conserved domains. (A) Model of the relative arrangement of the five conserved putative domains in the respective protein sequences of Edc3p and its homologs. The total length of each of the proteins is indicated at the right. The color-coded legend shows the domain numbers. (B) The protein sequences corresponding to the five conserved domains are aligned in Edc3p and its homologs. The residues in red are present in S. cerevisiae Edc3p and its homologs and the black residues represent the residues that are not conserved in S. cerevisiae Edc3p but may be conserved in the homologs from other organisms. The alignment was generated using the BLOCKS program (HENIKOFF et al. 1995 Down) that looks for regional conserved sequences in alignments. Accession numbers for the sequences are as follows: S. cereviseae, NP010901; S. pombe, NP595858; human, BAB15001; mouse, AAH31725; Drosophila, AAL25455; Anopheles, EAA08427.

Yeast strains and plasmids:
All strains used in this study are listed in Table 1. The NEO deletion cassette from the genomic DNA of the commercially available yel015w{Delta} mutant strain (Research Genetics, Birmingham, AL) was PCR amplified using the oligonucleotides oRP 1202 (5'-GAA GCA TAT CGT AAG CAC AC-3') and oRP 1203 (5'-GTG AGA CAC TGG CCT CGT CTG-3'). This amplified PCR fragment was used for transformation of the strains yRP840 and yRP841 to get yRP1745 and yRP1746 strains by homologous recombination.


 
View this table:
In this window
In a new window

 
Table 1. Strains used in this study

Growth phenotype studies were done with the dcp2-7ski3{Delta} edc3{Delta} and dcp1-2 ski8{Delta} edc3{Delta} strains, which were obtained by crossing edc3{Delta} with dcp2-7 ski3{Delta} and dcp1-2 ski8{Delta} strains and dissection of the diploid strains. The triple mutants were then grown along with the wild type (WT) and single and double mutants at 24°, 30°, and 37° for 3 days.

The construction of the Lsm1p-RFP plasmid is described in SHETH and PARKER 2003 Down. The EDC3-GFP strain construction was done as described in SHETH and PARKER 2003 Down. The Edc3p-GFP strain was transformed with the Lsm1p-RFP plasmid for the colocalization studies.

RNA procedures:
All RNA analyses were performed as described in MUHLRAD et al. 1994 Down. For half-life measurements cells were grown to midlog phase containing 2% galactose. Cells were harvested and transcription was repressed by the addition of media containing 4% glucose. Aliquots were taken over a brief time course and frozen. Yeast total RNA extractions were performed as described in MUHLRAD et al. 1994 Down and CAPONIGRO et al. 1993 Down. RNA was analyzed by running 10 µg of total RNA on either a 1.5% formaldehyde agarose gel as in Fig 2 and Fig 3 or a 6% polyacrylamide/7.5 M urea gel as in Fig 4. All Northerns were performed using radiolabeled oligo probes directed against the MFA2pG reporter (oRP140) and the 7S RNA (oRP100). For the CYH2 Northern blot, a random-prime radiolabeled CYH2 complementary DNA probe was used (THARUN et al. 2000 Down). Half-lives were determined by quantitation of blots using a Molecular Dynamics (Sunnyvale, CA) Phosphorimager. Loading correction for quantitations was determined by hybridization with oRP100, an oligo directed to the 7S RNA, a stable RNA polymerase III transcript. Northerns shown in Fig 2, Fig 3, and Fig 5 were done at least three times.



View larger version (63K):
In this window
In a new window
Download PPT slide
 
Figure 2. Edc3p is not rate limiting for mRNA decay. Shown is the decay of the MFA2pG reporter following transcriptional repression in WT and edc3{Delta} strains. Time points indicated at the top represent minutes after transcriptional repression. The distribution of the full-length (FL) MFA2pG mRNA relative to the smaller 5'–3' degradation intermediate (FR fragment) is shown. The amount of smaller 5'–3' degradation product is a measure of decapping activity in the strains shown. The half-life of the MFA2pG reporter is shown on the right. Hybridizations were performed with an oligonucleotide specific for the MFA2pG reporter (oRP 140; CAPONIGRO and PARKER 1996 Down). The oligo ORP 100 directed against the 7S RNA was used as a loading control. The experiment was performed as described in MATERIALS AND METHODS.



View larger version (82K):
In this window
In a new window
Download PPT slide
 
Figure 3. Edc3p is required for efficient mRNA decay in strains compromised for mRNA decapping activity. The decay of the MFA2pG reporter mRNA after transcription repression by addition of glucose in edc3{Delta} combined with dcp1-2, dcp2-7, lsm1{Delta}, dhh1{Delta}, and pat1{Delta} strains is shown along with the control strains. Time points indicated at the top represent minutes after transcriptional repression. FL and FR represent the full length and fragment of the MFA2pG transcript. The bottom shows the loading control using the oligo for the 7S RNA, oRP100. The half-life of the MFA2pG reporter is shown on the right. The experiment was performed as described in MATERIALS AND METHODS.



View larger version (110K):
In this window
In a new window
Download PPT slide
 
Figure 4. Edc3p interacts with the decapping proteins Dcp1p and Dcp2p. EDC3 was deleted in the dcp1-2 ski3{Delta} (A) and dcp2-7 ski8{Delta} (B) strain backgrounds and the growth of these strains at the indicated temperatures was monitored. The edc3{Delta} slows growth and causes synthetic lethality in strains compromised for mRNA decay at otherwise permissive temperatures for dcp1-2 ski3{Delta} and dcp2-7 ski8{Delta} strains.



View larger version (54K):
In this window
In a new window
Download PPT slide
 
Figure 5. edc3{Delta} affects the decapping step of mRNA decay. mRNA deadenylation of MFA2 transcripts after transcriptional repression from WT, edc3{Delta}, dcp2-7, and edc3{Delta} dcp2-7 strains is shown on polyacrylamide Northern blots. Each first lane is a sample treated with RNaseH in the presence of oligo(dT) to remove the poly(A) tail. The positions of the full-length polyadenylated species, nonadenylated species, and the decay intermediate are shown. The time points after transcriptional repression are shown at the top.

A primer extension analysis was performed as described in HATFIELD et al. 1996 Down. Oligo oRP131, which is complementary to the 5' end of the PGK1 transcript, was radiolabeled and added to 20 µg of total RNA. Extension was performed using superscribe reverse transcriptase (GIBCO BRL, Gaithersburg, MD). The reactions were analyzed on 6% polyacrylamide gels and visualized using autoradiographs. The primer extension data shown in Fig 6 are representative of three independent experiments.



View larger version (112K):
In this window
In a new window
Download PPT slide
 
Figure 6. edc3{Delta} mutants are not defective in 3'–5' exonucleolytic decay. The primer oRP131, specific for the PGK1pG reporter, was used for the primer extension analysis in WT, dcp1{Delta}, xrn1{Delta}, edc3{Delta}, dcp2-7, and edc3{Delta} dcp2-7 strains. After primer extension using reverse transcriptase, the samples were analyzed on a 6% polyacrylamide gel and visualized using autoradiographs. The asterisk indicates the expected -2 species below the full-length band in the xrn1{Delta} strain.

Confocal microscopy:
The cells were grown to an OD of 0.4 at 30° in synthetic medium containing 2% dextrose, washed, resuspended in a smaller volume of the media, and observed. Observations were made as described in SHETH and PARKER 2003 Down. The Edc3p-GFP strain with the LSM1-RFP plasmid was grown to an OD of 0.4 at 30° on synthetic media containing 2% dextrose without uracil. The cells were collected and observed as described above. All images shown in Fig 7 are representative of at least three independent observations.



View larger version (40K):
In this window
In a new window
Download PPT slide
 
Figure 7. Edc3p localizes to discrete cytoplasmic foci in the cell. (A) Edc3p was tagged with GFP as described in LONGTINE et al. 1998 Down. Cells were grown to 0.3 OD in synthetic medium containing 2% dextrose at 30° and then visualized using the confocal microscope as described in MATERIALS AND METHODS. Cells were treated with 100 µg/ml cycloheximide for 10 min and then analyzed for the presence of the foci. (B) Strains with Edc3p-GFP were transformed with the Lsm1p-RFP plasmid and were examined for colocalization of the two proteins using Adobe Photoshop.


*  RESULTS
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Edc3p belongs to a novel class of conserved proteins:
To evaluate the possible significance of Edc3p, we first examined databases for homologs in other organisms. By a series of BLAST (ALTSCHUL et al. 1990 Down) searches we were able to identify related proteins in several other organisms, including Schizosaccharomyces pombe, S. castelli (not shown), S. kluyvri (not shown), Homo sapiens, mouse, Drosophila, and Anopheles (Fig 1). Comparative sequence analysis showed that the S. cerevisiae Edc3p showed 21–28% identity with its homologs in these organisms. Interestingly, all the homologs of Edc3p are proteins of unknown function.

To determine which regions of Edc3p might be important for its function, we looked for conserved regions by several approaches. When Edc3p and its homologs were aligned using BLAST, a global alignment algorithm, no striking regions of similarity were observed. However, on using the alignment algorithms, CLUSTALW (THOMPSON et al. 1994 Down) and BLOCKS (HENIKOFF et al. 1995 Down), which look for regions of similarity over short stretches in the proteins, the EDC3 class of proteins showed five conserved domains arranged in the same order in all the homologs except the S. pombe homolog, where domain V is rearranged and positioned after domain I (Fig 1). The conservation of these regions supports the identification of these proteins as being homologs and suggests that these are functionally significant regions within the Edc3p.

Edc3p is not rate limiting for mRNA decay:
The extensive interactions/associations between Edc3p and different proteins involved in mRNA decay suggested that Edc3p might be involved in mRNA decay. To determine the role of Edc3p in mRNA decay, we created an edc3{Delta} strain, which grew normally at temperatures between 18° and 37°. We then analyzed the turnover of two reporter mRNAs in the edc3{Delta} strain. Analysis of mRNA degradation in these strains revealed no defect in the decay of either the unstable MFA2pG reporter mRNA (Fig 2) or the stable PGK1pG mRNA (data not shown). For example, the half-life of MFA2pG reporter mRNA was 4.6 min in the edc3{Delta} strain, which is not significantly different from the 4-min half-life of MFA2pG in the wild-type strain. This suggests that Edc3p either is not involved in mRNA decay or affects a step in decapping that is not rate limiting in vivo.

edc3{Delta} slows mRNA decay in strains compromised for the mRNA decay:
Given the extensive interactions with decapping factors, we hypothesized that Edc3p was involved in mRNA decapping, but affected a step that was not rate limiting. This interpretation was consistent with previous results identifying multiple substeps in the decapping reaction (SCHWARTZ and PARKER 2000 Down) and revealing that defects in the decapping activator proteins, Edc1 and Edc2, show a decay defect only when cells are partially compromised for mRNA decapping activity (DUNCKLEY et al. 2001 Down). Therefore, to test if Edc3p has some role in mRNA decapping, we created double mutants where the edc3{Delta} was combined with several mutations affecting decapping at different steps in the process. Specifically, we combined edc3{Delta} with conditional alleles in subunits of the decapping enzyme, dcp1-2 and dcp2-7, which affect the actual activity of the decapping enzyme (DUNCKLEY et al. 2001 Down; SCHWARTZ et al. 2003 Down). In addition, we created double mutants where the edc3{Delta} was combined with dhh1{Delta}, pat1{Delta}, or lsm1{Delta}. These latter mutations affect an early step in the decapping pathway that is distinct from the actual catalytic cleavage (SCHWARTZ and PARKER 2000 Down; SCHWARTZ et al. 2003 Down; SHETH and PARKER 2003 Down).

We first analyzed the mRNA decay defects of the edc3{Delta} dcp1-2 and edc3{Delta} dcp2-7 mutant strains. These experiments were done at 24°, which is the permissive temperature for both dcp1-2 and dcp2-7 alleles. At this temperature, dcp1-2 and dcp2-7 alleles are very slightly defective in mRNA decay in vivo at the permissive temperature (DUNCKLEY et al. 2001 Down; and Fig 3). When the edc3{Delta} was combined with either the dcp1-2 or the dcp2-7 background we observed a decrease in the rate of decay of the MFA2pG (Fig 3) and the PGK1pG mRNA (data not shown). In the dcp2-7 background, the edc3{Delta} slowed the MFA2pG mRNA decay by at least twofold so that the half-life for the MFA2pG mRNA was increased to 12 min compared to the 5 min in strains with just the dcp2-7 allele. The effect on MFA2pG half-life was not so dramatic (7.2 min) in the dcp1-2 strains deleted for the EDC3 gene compared to the dcp1-2 strain alone (4 min). These results indicate that when Dcp2p, and possibly Dcp1p, are partially defective, a role for Edc3p in mRNA decay can be observed. In contrast, when the edc3{Delta} was combined with the dhh1{Delta}, lsm1{Delta}, or pat1{Delta}, no affect on decay rate was observed (Fig 3). We interpret these results to indicate that Edc3p functions as an enhancer of mRNA decapping and genetically interacts most strongly with the actual decapping enzyme.

Loss of EDC3 slows growth in cells compromised for mRNA decapping:
To obtain additional evidence that Edc3p affected decapping, we utilized a growth assay where the viability of the strains is dependent on efficient mRNA decapping. This assay is based on the observation that strains lacking both the major deadenylation-dependent decapping pathway and the alternative 3'–5' degradation pathway are dead (JACOBS et al. 1998 Down; VAN HOOF et al. 2000 Down). This synthetic lethality can be made conditional by combining temperature-sensitive alleles of the DCP1 (dcp1-2) and DCP2 (dcp2-7) genes with strains having defects in the exosome-mediated 3'–5' decay pathway such as ski3{Delta} or ski8{Delta}. For example, a dcp1-2 ski8{Delta} strain grows at 24°, but is dead at 33° (JACOBS et al. 1998 Down). Similarly, dcp2-7 ski3{Delta} grows at 24° and 30° but is dead at 37° (DUNCKLEY et al. 2001 Down). These strains are conducive for studying effects of proteins that have a subtle effect on decapping. For example, if Edc3p reduces the function of the decapping enzyme, then edc3{Delta} should exacerbate the growth defect in the dcp1-2 ski8{Delta} and dcp2-7 ski3{Delta} strains and we would see a synthetic lethality at a temperature <33° or 37°.

We observed that combining the edc3{Delta} in strains with the dcp1-2 ski8{Delta} and dcp2-7 ski3{Delta} did lead to a clear exacerbation of the growth defects (Fig 4). At 24°, the dcp2-7 ski3{Delta} edc3{Delta} had an extremely slow growth phenotype compared to just the dcp2-7 ski3{Delta}. Moreover, the dcp2-7 ski3{Delta} edc3{Delta} failed to grow at 30° in comparison to the dcp2-7 ski3{Delta} that showed normal growth. Combination of edc3{Delta} with dcp1-2 ski8{Delta} also showed a growth defect phenotype at 30°, but almost normal growth at 24° in comparison to just the dcp1-2 ski8{Delta} strain that grows normally at both 30° and 24°. These growth defects correspond well with the mRNA decay phenotype of these mutants where Edc3p showed a greater defect when combined with the dcp2-7 allele than when combined with the dcp1-2 allele. These data provide a second line of genetic evidence for Edc3p affecting decapping.

Edc3p deletion affects the decapping step in mRNA decay:
Mutations affecting the mRNA decay rate in yeast can be at any step during deadenylation, decapping, or 5'–3' exonucleolytic degradation. The edc3{Delta} showed an mRNA decay defect phenotype only when combined in strains with either the dcp1-2 or the dcp2-7 mutation. Therefore, the most probable hypothesis is that Edc3p affects the decapping step of mRNA decay, which would be consistent with known Edc3p physical interactions. To determine what step in decapping Edc3p affects, we compared the decay of the MFA2pG mRNA in dcp2-7 strains to dcp2-7 edc3{Delta} strains on polyacrylamide Northern gels, where the rates of deadenylation and subsequent decay can be observed. On analysis of the MFA2pG mRNA, we observed that there was no substantial difference in the deadenylation rate of the MFA2pG mRNA among the wild type, edc3{Delta}, dcp2-7, or dcp2-7 edc3{Delta} strains (Fig 5). This indicates that Edc3p does not affect the deadenylation rate. However, we did observe that the decay of the deadenylated species was slower in the dcp2-7 edc3{Delta} as compared to dcp2-7 strains alone. This observation suggests that the Edc3p promotes either decapping or 5'–3' exonucleolytic degradation in the dcp2-7 strain.

A defect in mRNA decapping can be distinguished from a defect in the exonucleolytic digestion by a primer extension assay. This assay takes advantage of the observation that strains defective in 5'–3' degradation accumulate a decapped PGK1 transcript that is two nucleotides shorter at the 5' end compared to that of transcripts that still have the cap (HATFIELD et al. 1996 Down; ZUK et al. 1999 Down; COLLER et al. 2001 Down). Given this, we examined the 5' ends of the PGK1 mRNA in edc3{Delta}, dcp2-7 edc3{Delta}, and various control strains including the xrn1{Delta} strain (lacking the 5'–3' exonuclease) and dcp1{Delta} (lacking the decapping enzyme) strains. We observed that the dcp2-7 edc3{Delta} strain, where there is a defect in decay after deadenylation, contains a full-length transcript similar to only the wild-type and dcp1{Delta} strains. Further, the edc3{Delta} mutants did not have a defect exclusively in the 3'–5' exonuclease activity. In contrast, the xrn1{Delta} strain shows the full-length transcript and a -2-nucleotide (nt) species (Fig 6). The above observations provide evidence that Edc3p affects the decapping step of mRNA degradation. However, it should be noted that we cannot rule out that Edc3p also affects the 5'–3' degradation step.

Edc3p localizes to cytoplasmic foci similar to the P-bodies:
It has been recently shown that the proteins involved specifically in mRNA decapping in yeast and mammals are concentrated in cytoplasmic foci called P-bodies (INGELFINGER et al. 2002 Down; LYKKE-ANDERSEN 2002 Down; VAN DIJK et al. 2002 Down; SHETH and PARKER 2003 Down). Given this observation, if Edc3p is involved in the mRNA decapping step, we would predict that Edc3p would be present in P-bodies. To assess this possibility, we constructed a C-terminal green fluorescent protein (GFP) fusion of Edc3p and localized the protein in the cell by confocal microscopy. We observed that Edc3p-GFP is present in discrete foci in the cytoplasm similar to P-bodies (Fig 7A). The identity of these foci as P-bodies is confirmed by the colocalization of Edc3p-GFP with red fluorescent protein (RFP)-tagged Lsm1p (Fig 7B). Thus, like other proteins involved in mRNA decapping, Edc3p also localizes to the P-bodies. Interestingly, we observed a greater number of Edc3p-GFP foci as compared to the Lsm1p-RFP foci (Fig 7B). One possibility is that different forms of P-bodies exist, some of which are lacking Lsm1p, or another possibility is that we failed to detect Lsm1p in all P-bodies due to the lower signal from the Lsm1p-RFP fusion.

Additional supporting evidence that the Edc3p-GFP foci are P-bodies comes from the observation that trapping mRNAs in polysomes using cycloheximide inhibits decapping and leads to loss of P-bodies after treatment with the drug (SHETH and PARKER 2003 Down). Just like P-bodies, the Edc3p-GFP foci also disappeared rapidly on treatment of the cells with cycloheximide (Fig 7A).

Edc3p does not affect nonsense-mediated decay:
The decapping complex is also involved in nonsense-mediated decay (NMD), which is characterized by deadenylation-independent decapping; therefore we asked if Edc3p plays a role in NMD (WILUSZ et al. 2001 Down; LYKKE-ANDERSEN 2002 Down). To determine if Edc3p affects NMD, the levels of the CYH2 pre-mRNA in edc3{Delta} and dcp2-7 edc3{Delta} strains were analyzed. A known NMD substrate is the CYH2 pre-mRNA, which is inefficiently spliced and contains a pretermination codon (PTC; HE et al. 1993 Down; HILLEREN and PARKER 1999 Down). Analysis of CYH2 mRNA at steady state showed that the edc3{Delta} did not lead to increased levels of pre-CYH2 mRNA either in wild-type strains or in combination with dcp1-2 and dcp2-7 alleles (Fig 8). These results suggest that Edc3p does not play a significant role in NMD.



View larger version (47K):
In this window
In a new window
Download PPT slide
 
Figure 8. Edc3p is not essential for NMD. The steady-state levels of CYH2 pre-mRNA and mRNA in WT, upf1{Delta}, trp, edc3{Delta}, dcp1-2, dcp2-7, edc3{Delta} dcp1-2, and edc3{Delta} dcp2-7 strains are shown. The lane second from the right is empty. Steady-state RNA from cells grown at 30° was isolated and analyzed on agarose Northern, using a random-primer-labeled probe that is specific for both pre-mRNA and mRNA of CYH2. The oligo oRP100 directed against the 7S RNA was used as a loading control. The ratio of the CYH2 pre-mRNA and mRNA in all the strains was calculated (not shown).


*  DISCUSSION
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

Several observations indicate that Edc3p has a role in mRNA decay and specifically enhances the function of decapping. First, Edc3p has been shown in numerous in vivo and in vitro genomic studies to physically interact with several mRNA decay factors (FROMONT-RACINE et al. 2000 Down; UETZ et al. 2000 Down; ITO et al. 2001 Down; GAVIN et al. 2002 Down; HO et al. 2002 Down). Second, deletion of the EDC3 gene leads to a defect in mRNA degradation in strains carrying conditional alleles of Dcp1p and Dcp2p, even though the analysis is done at permissive temperatures where the dcp1-2 and dcp2-7 alleles have little or no effect on mRNA decay rates (Fig 3). Moreover, these edc3{Delta} dcp2-7 strains accumulated deadenylated full-length MFA2pG reporter mRNA compared to the WT, edc3{Delta}, and dcp2-7 allele alone (Fig 5). Third, edc3{Delta} exaggerated growth defects and caused synthetic lethality in strains containing the dcp1-2 and dcp2-7 alleles in combination with a block to the 3'–5' decay pathway (Fig 4). Finally, an Edc3p-GFP fusion protein localizes in P-bodies (Fig 7), which are specialized cytoplasmic foci containing decapping proteins (SHETH and PARKER 2003 Down). These observations together argue that Edc3p interacts with Dcp2p and Dcp1p to stimulate the mRNA decapping rate.

In principle, Edc3p could enhance decapping by acting at any of several distinct steps in the decapping process. Although poorly understood, previous experiments have suggested that decapping will require at least three distinct, but possibly related steps: (1) loss of the translation initiation complex bound to the 5' end of the mRNA, (2) assembly of a decapping complex and localization within P-bodies, and (3) the actual catalytic step of decapping (SCHWARTZ and PARKER 2000 Down; THARUN and PARKER 2001 Down; SHETH and PARKER 2003 Down).

Three observations are consistent with Edc3p primarily affecting the final step of enzymatic decapping, either by stabilizing Dcp1p/Dcp2p or by affecting their function in some manner. First, the edc3{Delta} shows only synergistic effects with other defects in the decapping activity and does not show any phenotypic interaction with deletions in the LSM1, PAT1, and DHH1 genes, whose products are likely to affect the first two steps in the decapping process. Second, on the basis of copurification, Edc3p directly interacts with Dcp1p/Dcp2p (FROMONT-RACINE et al. 2000 Down; UETZ et al. 2000 Down; ITO et al. 2001 Down; GAVIN et al. 2002 Down; HO et al. 2002 Down). Third, the edc3{Delta} does not have a decay defect and previous results suggest that the actual decapping step in decay is not normally rate limiting. Evidence that the enzymatic decapping step is not rate limiting in vivo in our growth conditions is that the dcp1-2, dcp2-7, edc1{Delta}, and edc2{Delta} mutations all strongly affect mRNA decapping activity in vitro, yet have little effect on overall decay rate in vivo (DUNCKLEY et al. 2001 Down; SCHWARTZ et al. 2003 Down). However, it should be noted that decapping per se could be made the rate-limiting step in decapping in vivo (as in a strong dcp1 or dcp2 allele).

The Edc3p is part of an emerging set of proteins that perform the mRNA decapping step. Proteins involved in mRNA decay can be divided into three functional and phenotypic categories. The first class of proteins consists of Dcp1p and Dcp2p, which are required for the decapping enzyme to function, and strains lacking these proteins show a complete block to decapping (BEELMAN et al. 1996 Down; DUNCKLEY and PARKER 1999 Down; THARUN and PARKER 1999 Down). The second group of decapping regulatory proteins (Lsm1-7p, Pat1p, and Dhh1p) appears to constitute a general activator of decapping complex. Strains lacking Lsm1-7p, Dhh1p, or Pat1p show a partial block to decapping for multiple mRNAs. Edc3p belongs to the third class of decapping factors, which, although they can affect the decapping process, are not normally rate limiting for decapping. The proteins Edc1p and Edc2p are also in this class.

Recent results suggest that the EDC family of proteins may also be important in the control of a subset of mRNAs or in the control of decapping under different conditions. For example, Edc1p has been shown to be important for growth during a shift from dextrose to glycerol, suggesting that it may be affecting specific mRNAs necessary for this carbon-source shift (SCHWARTZ et al. 2003 Down). In addition, recent results show that Edc3p specifically affects the decapping of the RPS28B mRNA, possibly as part of an autoregulatory loop (G. BADIS, C. SAVEANU, M. FROMONT-RACINE and A. JACQUIER, unpublished results). Given these results, the emerging picture of the EDC family of proteins is that they will play a general role in assisting decapping and have been coopted for the control of specific mRNAs. An unresolved issue is how broad the specific role of these proteins will be in the cell.


*  ACKNOWLEDGMENTS

We thank the Parker laboratory for helpful discussions; Ujwal Sheth for the Edc3p-GFP strain and the LSM1-RFP plasmid; and Kristian Baker, Jeffery Coller, Carolyn Decker, Tharun Sundaresan, and Daniela Teixiera for experimental and intellectual assistance. We also thank Alain Jacquier for sharing unpublished results. A National Institutes of Health grant (GM45443) and funds from the Howard Hughes Medical Institute supported this work.

Manuscript received July 8, 2003; Accepted for publication October 27, 2003.


*  LITERATURE CITED
*TOP
*ABSTRACT
*MATERIALS AND METHODS
*RESULTS
*DISCUSSION
*LITERATURE CITED

ALTSCHUL, S. F., W. GISH, W. MILLER, E. W. MYERS, and D. J. LIPMAN, 1990  Basic local alignment search tool. J. Mol. Biol. 215:403-410.[CrossRef][Medline]

BEELMAN, C. A., A. STEVENS, G. CAPONIGRO, T. E. LAGRANDEUR, and L. HATFIELD et al., 1996  An essential component of the decapping enzyme required for normal rates of mRNA turnover. Nature 382:642-646.[CrossRef][Medline]

BONNEROT, C., R. BOECK, and B. LAPEYRE, 2000  The two proteins Pat1p (Mrt1p) and Spb8p interact in vivo, are required for mRNA decay, and are functionally linked to Pab1p. Mol. Cell. Biol. 20:5939-5946.[Abstract/Free Full Text]

BOUVERET, E., G. RIGAUT, A. SHEVCHENKO, M. WILM, and B. SERAPHIN, 2000  A Sm-like protein complex that participates in mRNA degradation. EMBO J. 19:1661-1671.[CrossRef][Medline]

CAPONIGRO, G. and R. PARKER, 1996  mRNA turnover in yeast promoted by the MATalpha1 instability element. Nucleic Acids Res. 24:4304-4312.[Abstract/Free Full Text]

CAPONIGRO, G., D. MUHLRAD, and R. PARKER, 1993  A small segment of the MAT alpha 1 transcript promotes mRNA decay in Saccharomyces cerevisiae: a stimulatory role for rare codons. Mol. Cell. Biol. 13:5141-5148.[Abstract/Free Full Text]

CHEN, J., Y. C. CHIANG, and C. L. DENIS, 2002  CCR4, a 3'-5' poly (A) RNA and ssDNA exonuclease, is the catalytic component of the cytoplasmic deadenylase. EMBO J. 21:1414-1426.[CrossRef][Medline]

COLLER, J. M., M. TUCKER, U. SHETH, M. A. VALENCIA-SANCHEZ, and R. PARKER, 2001  The DEAD box helicase, Dhh1p, functions in mRNA decapping and interacts with both the decapping and deadenylase complexes. RNA 7:1717-1727.[Abstract]

DAUGERON, M. C., F. MAUXION, and B. SERAPHIN, 2001  The yeast POP2 gene encodes a nuclease involved in mRNA deadenylation. Nucleic Acids Res. 29:2448-2455.[Abstract/Free Full Text]

DECKER, C. J. and R. PARKER, 1993  A turnover pathway for both stable and unstable mRNAs in yeast: evidence for a requirement for deadenylation. Genes Dev. 7:1632-1643.[Abstract/Free Full Text]

DUNCKLEY, T. and R. PARKER, 1999  The DCP2 protein is required for mRNA decapping in Saccharomyces cerevisiae and contains a functional MutT motif. EMBO J. 18:5411-5422.[CrossRef][Medline]

DUNCKLEY, T., M. TUCKER, and R. PARKER, 2001  Two related proteins, Edc1p and Edc2p, stimulate mRNA decapping in Saccharomyces cerevisiae. Genetics 157:27-37.[Abstract/Free Full Text]

FISCHER, N. and K. WEIS, 2002  The DEAD box protein Dhh1 stimulates the decapping enzyme Dcp1. EMBO J. 21:2788-2797.[CrossRef][Medline]

FROMONT-RACINE, M., J. C. RAIN, and P. LEGRAIN, 1997  Toward a functional analysis of the yeast genome through exhaustive two-hybrid screens. Nat. Genet. 16:277-282.[CrossRef][Medline]

FROMONT-RACINE, M., A. E. MAYES, A. BRUNET-SIMON, J. C. RAIN, and A. COLLEY et al., 2000  Genome-wide protein interaction screens reveal functional networks involving Sm-like proteins. Yeast 17:95-110.[CrossRef][Medline]

GAVIN, A. C., M. BOSCHE, R. KRAUSE, P. GRANDI, and M. MARZIOCH et al., 2002  Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature 415:141-147.[CrossRef][Medline]

GIAEVER, G., A. M. CHU, L. NI, C. CONNELLY, and L. RILES et al., 2002  Functional profiling of the Saccharomyces cerevisiae genome. Nature 418:387-391.[CrossRef][Medline]

HATFIELD, L., C. A. BEELMAN, A. STEVENS, and R. PARKER, 1996  Mutations in trans-acting factors affecting mRNA decapping in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:5830-5838.[Abstract]

HE, F., S. W. PELTZ, J. L. DONAHUE, M. ROSBASH, and A. JACOBSON, 1993  Stabilization and ribosome association of unspliced pre-mRNAs in a yeast upf1- mutant. Proc. Natl. Acad. Sci. USA 90:7034-7038.[Abstract/Free Full Text]

HE, W. and R. PARKER, 2001  The yeast cytoplasmic LsmI/Pat1p complex protects mRNA 3' termini from partial degradation. Genetics 158:1445-1455.[Abstract/Free Full Text]

HENIKOFF, S., J. G. HENIKOFF, W. J. ALFORD, and S. PIETROKOVSKI, 1995  Automated construction and graphical presentation of protein blocks from unaligned sequences. Gene 163:GC17-GC26.[CrossRef][Medline]

HILLEREN, P. and R. PARKER, 1999  Mechanisms of mRNA surveillance in eukaryotes. Annu. Rev. Genet. 33:229-260.[CrossRef][Medline]

HISHIGAKI, H., K. NAKAI, T. ONO, A. TANIGAMI, and T. TAKAGI, 2001  Assessment of prediction accuracy of protein function from protein–protein interaction data. Yeast 18:523-531.[CrossRef][Medline]

HO, Y., A. GRUHLER, A. HEILBUT, G. D. BADER, and L. MOORE et al., 2002  Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature 415:180-183.[CrossRef][Medline]

HSU, C. L. and A. STEVENS, 1993  Yeast cells lacking 5'->3' exoribonuclease 1 contain mRNA species that are poly (A) deficient and partially lack the 5' cap structure. Mol. Cell. Biol. 13:4826-4835.[Abstract/Free Full Text]

INGELFINGER, D., D. J. ARNDT-JOVIN, R. LUHRMANN, and T. ACHSEL, 2002  The human LSm1–7 proteins colocalize with the mRNA-degrading enzymes Dcp1/2 and Xrnl in distinct cytoplasmic foci. RNA 8:1489-1501.[Abstract]

ITO, T., T. CHIBA, R. OZAWA, M. YOSHIDA, and M. HATTORI et al., 2001  A comprehensive two-hybrid analysis to explore the yeast protein interactome. Proc. Natl. Acad. Sci. USA 98:4569-4574.[Abstract/Free Full Text]

JACOBS, J. S., A. R. ANDERSON, and R. P. PARKER, 1998  The 3' to 5' degradation of yeast mRNAs is a general mechanism for mRNA turnover that requires the SKI2 DEVH box protein and 3' to 5' exonucleases of the exosome complex. EMBO J. 17:1497-1506.[CrossRef][Medline]

LONGTINE, M. S., A. MCKENZIE, III, D. J. DEMARINI, N. G. SHAH, and A. WACH et al., 1998  Additional modules for versatile and economical PCR-based gene deletion and modification in Saccharomyces cerevisiae. Yeast 14:953-961.[CrossRef][Medline]

LYKKE-ANDERSEN, J., 2002  Identification of a human decapping complex associated with hUpf proteins in nonsense-mediated decay. Mol. Cell. Biol. 22:8114-8121.[Abstract/Free Full Text]

MUHLRAD, D. and R. PARKER, 1992  Mutations affecting stability and deadenylation of the yeast MFA2 transcript. Genes Dev. 6:2100-2111.[Abstract/Free Full Text]

MUHLRAD, D., C. J. DECKER, and R. PARKER, 1994  Deadenylation of the unstable mRNA encoded by the yeast MFA2 gene leads to decapping followed by 5'->3' digestion of the transcript. Genes Dev. 8:855-866.[Abstract/Free Full Text]

MUHLRAD, D., C. J. DECKER, and R. PARKER, 1995  Turnover mechanisms of the stable yeast PGK1 mRNA. Mol. Cell. Biol. 15:2145-2156.[Abstract]

SCHWARTZ, D. C. and R. PARKER, 2000  mRNA decapping in yeast requires dissociation of the cap binding protein, eukaryotic translation initiation factor 4E. Mol. Cell. Biol. 20:7933-7942.[Abstract/Free Full Text]

SCHWARTZ, D., C. J. DECKER, and R. PARKER, 2003  The enhancer of decapping proteins, Edc1p and Edc2p, bind RNA and stimulate the activity of the decapping enzyme. RNA 9:239-251.[Abstract/Free Full Text]

SCHWIKOWSKI, B., P. UETZ, and S. FIELDS, 2000  A network of protein-protein interactions in yeast. Nat. Biotechnol. 18:1257-1261.[CrossRef][Medline]

SHETH, U. and R. PARKER, 2003  Decapping and decay of messenger RNA occur in cytoplasmic processing bodies. Science 300:805-808.[Abstract/Free Full Text]

STEIGER, M. A. and R. PARKER, 2002  Analyzing mRNA decay in Saccharomyces cerevisiae. Methods Enzymol. 351:648-660.[Medline]

STEIGER, M., A. CARR-SCHMID, D. C. SCHWARTZ, M. KILEDJIAN, and R. PARKER, 2003  Analysis of recombinant yeast decapping enzyme. RNA 9:231-238.[Abstract/Free Full Text]

THARUN, S. and R. PARKER, 1999  Analysis of mutations in the yeast mRNA decapping enzyme. Genetics 151:1273-1285.[Abstract/Free Full Text]

THARUN, S. and R. PARKER, 2001  Targeting an mRNA for decapping: displacement of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol. Cell 8:1075-1083.[CrossRef][Medline]

THARUN, S., W. HE, A. E. MAYES, P. LENNERTZ, and J. D. BEGGS et al., 2000  Yeast Sm-like proteins function in mRNA decapping and decay. Nature 404:515-518.[CrossRef][Medline]

THOMPSON, J. D., D. G. HIGGINS, and T. J. GIBSON, 1994  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.[Abstract/Free Full Text]

TUCKER, M. and R. PARKER, 2000  Mechanisms and control of mRNA decapping in Saccharomyces cerevisiae. Annu. Rev. Biochem. 69:571-595.[CrossRef][Medline]

TUCKER, M., M. A. VALENCIA-SANCHEZ, R. R. STAPLES, J. CHEN, and C. L. DENIS et al., 2001  The transcription factor associated Ccr4 and Caf1 proteins are components of the major cytoplasmic mRNA deadenylase in Saccharomyces cerevisiae. Cell 104:377-386.[CrossRef][Medline]

TUCKER, M., R. R. STAPLES, M. A. VALENCIA-SANCHEZ, D. MUHLRAD, and R. PARKER, 2002  Ccr4p is the catalytic subunit of a Ccr4p/Pop2p/Notp mRNA deadenylase complex in Saccharomyces cerevisiae. EMBO J. 21:1427-1436.[CrossRef][Medline]

UETZ, P., L. GIOT, G. CAGNEY, T. A. MANSFIELD, and R. S. JUDSON et al., 2000  A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-627.[CrossRef][Medline]

VAN DIJK, E., N. COUGOT, S. MEYER, S. BABAJKO, and E. WAHLE et al., 2002  Human Dcp2: a catalytically active mRNA decapping enzyme located in specific cytoplasmic structures. EMBO J. 21:6915-6924.[CrossRef][Medline]

VAN HOOF, A., R. R. STAPLES, R. E. BAKER, and R. PARKER, 2000  Function of the ski4p (Csl4p) and Ski7p proteins in 3'-to-5' degradation of mRNA. Mol. Cell. Biol. 20:8230-8243.[Abstract/Free Full Text]

WILUSZ, C. J., W. WANG, and S. W. PELTZ, 2001  Curbing the nonsense: the activation and regulation of mRNA surveillance. Genes Dev. 15:2781-2785.[Free Full Text]

ZUK, D., J. P. BELK, and A. JACOBSON, 1999  Temperature-sensitive mutations in the Saccharomyces cerevisiae MRT4, GRC5, SLA2 and THS1 genes result in defects in mRNA turnover. Genetics 153:35-47.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
F. Tritschler, A. Eulalio, S. Helms, S. Schmidt, M. Coles, O. Weichenrieder, E. Izaurralde, and V. Truffault
Similar Modes of Interaction Enable Trailer Hitch and EDC3 To Associate with DCP1 and Me31B in Distinct Protein Complexes
Mol. Cell. Biol., November 1, 2008; 28(21): 6695 - 6708.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. H. M. Ling, C. J. Decker, M. A. Walsh, M. She, R. Parker, and H. Song
Crystal Structure of Human Edc3 and Its Functional Implications
Mol. Cell. Biol., October 1, 2008; 28(19): 5965 - 5976.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
A. Chowdhury and S. Tharun
lsm1 mutations impairing the ability of the Lsm1p-7p-Pat1p complex to preferentially bind to oligoadenylated RNA affect mRNA decay in vivo
RNA, October 1, 2008; 14(10): 2149 - 2158.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Decourty, C. Saveanu, K. Zemam, F. Hantraye, E. Frachon, J.-C. Rousselle, M. Fromont-Racine, and A. Jacquier
Linking functionally related genes by sensitive and quantitative characterization of genetic interaction profiles
PNAS, April 15, 2008; 105(15): 5821 - 5826.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Marin, S. Golem, K. M. Rose, S. L. Kozak, and D. Kabat
Human Immunodeficiency Virus Type 1 Vif Functionally Interacts with Diverse APOBEC3 Cytidine Deaminases and Moves with Them between Cytoplasmic Sites of mRNA Metabolism
J. Virol., January 15, 2008; 82(2): 987 - 998.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. Tritschler, A. Eulalio, V. Truffault, M. D. Hartmann, S. Helms, S. Schmidt, M. Coles, E. Izaurralde, and O. Weichenrieder
A Divergent Sm Fold in EDC3 Proteins Mediates DCP1 Binding and P-Body Targeting
Mol. Cell. Biol., December 15, 2007; 27(24): 8600 - 8611.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
C. J. Decker, D. Teixeira, and R. Parker
Edc3p and a glutamine/asparagine-rich domain of Lsm4p function in processing body assembly in Saccharomyces cerevisiae
J. Cell Biol., November 5, 2007; 179(3): 437 - 449.
[Abstract] [Full Text] [PDF]